Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Atherosclerosis
|
January 1, 1987
Increased growth stimulation of human vascular cells by serum from patients with primary hyper-LDL-cholesterolemia
T Koschinsky, C E Bünting, R Rütter, et al.
Agents and Actions. Supplements
|
January 1, 1984
Hypercholesterolemic and diabetic serum decrease LDL-degradation by cathepsin D from human arterial smooth muscle cells and fibroblasts
T Koschinsky, C E Bünting, R Rütter, et al.
Monographs on Atherosclerosis
|
January 1, 1985
Apo B degradation in vascular cells is regulated by metabolic control of diabetes
T Koschinsky, C E Bünting, R Rütter, et al.
Diabete & Metabolisme
|
July 1, 1987
Vascular growth factors and the development of macrovascular disease in diabetes mellitus
T Koschinsky, C E Bünting, R Rütter, et al.
Hormone and Metabolic Research. Supplement Series
|
January 1, 1985
Vascular growth factors and the development of macrovascular disease in diabetes mellitus
T Koschinsky, C E Bünting, R Rütter, et al.
Diabetologia
|
April 1, 1985
Sera from type 2 (non-insulin-dependent) diabetic and healthy subjects contain different amounts of a very low molecular weight growth peptide for vascular cells
T Koschinsky, C E Bünting, R Rütter, et al.
Monographs on Atherosclerosis
|
January 1, 1985
Diabetic serum growth factor: a new low molecular weight growth peptide for arterial smooth muscle cells of platelet origin
T Koschinsky, C E Bünting, R Rütter, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Atherosclerosis
|
January 1, 1987
Increased growth stimulation of human vascular cells by serum from patients with primary hyper-LDL-cholesterolemia
T Koschinsky, C E Bünting, R Rütter, et al.
Agents and Actions. Supplements
|
January 1, 1984
Hypercholesterolemic and diabetic serum decrease LDL-degradation by cathepsin D from human arterial smooth muscle cells and fibroblasts
T Koschinsky, C E Bünting, R Rütter, et al.
Monographs on Atherosclerosis
|
January 1, 1985
Apo B degradation in vascular cells is regulated by metabolic control of diabetes
T Koschinsky, C E Bünting, R Rütter, et al.
Diabete & Metabolisme
|
July 1, 1987
Vascular growth factors and the development of macrovascular disease in diabetes mellitus
T Koschinsky, C E Bünting, R Rütter, et al.
Hormone and Metabolic Research. Supplement Series
|
January 1, 1985
Vascular growth factors and the development of macrovascular disease in diabetes mellitus
T Koschinsky, C E Bünting, R Rütter, et al.
Diabetologia
|
April 1, 1985
Sera from type 2 (non-insulin-dependent) diabetic and healthy subjects contain different amounts of a very low molecular weight growth peptide for vascular cells
T Koschinsky, C E Bünting, R Rütter, et al.
Monographs on Atherosclerosis
|
January 1, 1985
Diabetic serum growth factor: a new low molecular weight growth peptide for arterial smooth muscle cells of platelet origin
T Koschinsky, C E Bünting, R Rütter, et al.
Page
of 1